TIMEA TUROCZI: Open Payments
NPI 1497077572 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 26 payments from 7 companies in 2025. Trend: 2023 $855 · 2024 $781 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $301 |
| Vanda Pharmaceuticals Inc. | 5 | $178 |
| Otsuka America Pharmaceutical, Inc. | 6 | $119 |
| Supernus Pharmaceuticals, Inc. | 5 | $84 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Corium, LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: ARISTADA, FANAPT, LYBALVI, REXULTI, Qelbree, Jornay PM, HETLIOZ, Azstarys.
Industry payments across OH — which companies pay providers there.
